| Phase 4 |
| NCT06909214 |
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With… |
New Onset Generalized Myasthenia Gravis (gMG) |
Recruiting |
2026-03-10 |
| Phase 3 |
| NCT06920004 |
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP |
Chronic Inflammatory Demyelinating Polyneuropathy |
Recruiting |
2026-09-24 |
| NCT07091630 |
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP |
Chronic Inflammatory Demyelinating Polyneuropathy |
Recruiting |
2026-09-24 |
| NCT07570316 |
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… |
Graves' Disease |
Recruiting |
2026-09-24 |
| NCT07596849 |
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… |
Graves Disease |
Recruiting |
2026-09-24 |
| NCT06544499 |
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With… |
Primary Immune Thrombocytopenia (ITP) |
Recruiting |
2026-05-01 |
| NCT04812925 |
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in… |
Primary Immune Thrombocytopenia |
Active, Not Recruiting |
2026-09-23 |
| NCT06742190 |
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With… |
Multifocal Motor Neuropathy (MMN) |
Active, Not Recruiting |
2026-09-22 |
| NCT05979441 |
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of… |
Myositis |
Enrolling by Invitation |
2026-09-21 |
| NCT06298552 |
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With… |
Generalized Myasthenia Gravis |
Active, Not Recruiting |
2026-08-10 |
| NCT07746089 |
A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants… |
Congenital Myasthenic Syndrome |
Not Yet Recruiting |
2026-08-04 |
| NCT06558279 |
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular… |
Myasthenia Gravis, Ocular |
Active, Not Recruiting |
2026-07-02 |
| NCT06684847 |
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's… |
Primary Sjogrens Disease |
Active, Not Recruiting |
2026-04-16 |
| Phase 2/3 |
| NCT06392386 |
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With… |
Generalized Myasthenia Gravis |
Recruiting |
2026-09-28 |
| NCT07194850 |
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age… |
Immune Thrombocytopenia (ITP) |
Recruiting |
2026-09-24 |
| NCT04833894 |
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod… |
Generalized Myasthenia Gravis |
Recruiting |
2026-02-18 |
| NCT07638566 |
A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent… |
Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
Not Yet Recruiting |
2026-06-10 |
| NCT05374590 |
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod… |
Generalized Myasthenia Gravis |
Enrolling by Invitation |
2026-04-23 |
| Phase 2 |
| NCT06655155 |
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic… |
Systemic Sclerosis (SSc) |
Recruiting |
2026-09-24 |
| NCT07284420 |
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to… |
AChR-Ab Seropositive Generalized Myasthenia Gravis |
Recruiting |
2026-09-24 |
| NCT07673627 |
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of… |
AChR-Ab Seropositive Generalized Myasthenia Gravis |
Recruiting |
2026-09-24 |
| NCT07287982 |
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and… |
Spinal Muscular Atrophy (SMA) |
Recruiting |
2026-09-14 |
| NCT05907096 |
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function |
Delayed Graft Function |
Active, Not Recruiting |
2026-09-25 |
| NCT07821762 |
A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With… |
Guillain-Barré Syndrome (GBS) |
Not Yet Recruiting |
2026-09-25 |
| NCT07773727 |
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult… |
Immunoglobulin A Nephropathy (IgAN) |
Not Yet Recruiting |
2026-09-23 |